Precision BioSciences

In News

Precision gains FDA approval to begin Phase I/II FUNCTION-DMD trial - Clinical Trials Arena

Clinical Trials Arena - Feb 13, 2026

Precision BioSciences Receives U.S. FDA Clearance of Investigational New Drug Application for First-in-Class PBGENE-DMD for Treatment of Duchenne Muscular Dystrophy - Business Wire

Business Wire - Feb 11, 2026

Precision Biosciences’ PBGENE-DMD cleared to enter clinic - BioWorld MedTech

BioWorld MedTech - Feb 11, 2026

Precision BioSciences cleared by FDA to launch groundbreaking Duchenne gene editing trial - Indian Pharma Post

Indian Pharma Post - Feb 14, 2026

Precision BioSciences Receives FDA Clearance for PBGENE-DMD Program - TradingView

TradingView - Feb 11, 2026

Precision BioSciences receives U.S. FDA clearance of investigational new drug application for first-in-class PBgene-Dmd for treatment of Duchenne muscular dystrophy - marketscreener.com

marketscreener.com - Feb 11, 2026

Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha

Seeking Alpha - Dec 29, 2025

Precision BioSciences, Inc. (NASDAQ:DTIL) Short Interest Update - MarketBeat

MarketBeat - Feb 03, 2026

Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants - Latham & Watkins LLP

Latham & Watkins LLP - Nov 11, 2025

Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

Yahoo Finance - Nov 03, 2025

Precision BioSciences and Vir Biotechnology: Undates on HBV and HDV - European AIDS Treatment Group

European AIDS Treatment Group - Aug 11, 2025

A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st

simplywall.st - Oct 31, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment